An Adaptive Model Predictive Controller to Address the Biovariability in Blood Clotting Response During Therapy With Warfarin
Open Access
- 27 March 2023
- journal article
- research article
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Biomedical Engineering
- Vol. 70 (9) , 2667-2678
Abstract
Objective: Effective dosing of anticoagulants aims to prevent blood clot formation while avoiding hemorrhages. This complex task is challenged by several disturbing factors and drug-effect uncertainties, requesting frequent monitoring and adjustment. Biovariability in drug absorption and action further complicates titration and calls for individualized strategies. In this paper, we propose an adaptive closed-loop control algorithm to assist in warfarin therapy management. Methods: The controller was designed and tested in silico using an established pharmacometrics model of warfarin, which accounts for inter-subject variability. The control algorithm is an adaptive Model Predictive Control (a-MPC) that leverages a simplified patient model, whose parameters are updated with a Bayesian strategy. Performance was quantitatively evaluated in simulations performed on a population of virtual subjects against an algorithm reproducing medical guidelines (MG) and an MPC controller available in the literature (l-MPC). Results: The proposed a-MPC significantly (p $< $ 0.05) lowers rising time (2.8 vs. 4.4 and 11.2 days) and time out of range (3.3 vs. 7.2 and 12.9 days) with respect to both MG and l-MPC, respectively. Adaptivity grants a significantly (p $< $ 0.05) lower number of subjects reaching unsafe INR values compared to when this feature is not present (8.9% vs.15% of subjects presenting an overshoot outside the target range and 0.08% vs. 0.28% of subjects reaching dangerous INR values). Conclusion: The a-MPC algorithm improve warfarin therapy compared to the benchmark therapies. Significance: This in-silico validation proves effectiveness of the a-MPC algorithm for anticoagulant administration, paving the way for clinical testing.Keywords
Funding Information
- MIUR, Italian Minister for Education
- Dipartimenti di Eccellenza (Law 232/2016)
This publication has 33 references indexed in Scilit:
- Optimized treatment of fibromyalgia using system identification and hybrid model predictive controlControl Engineering Practice, 2014
- The University of Virginia/Padova Type 1 Diabetes Simulator Matches the Glucose Traces of a Clinical TrialDiabetes Technology & Therapeutics, 2014
- Optimal dosing of cancer chemotherapy using model predictive control and moving horizon state/parameter estimationComputer Methods and Programs in Biomedicine, 2012
- Prediction of Warfarin Dose: Why, When and How?Pharmacogenomics, 2012
- Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin DosingClinical Pharmacology & Therapeutics, 2011
- Simulation Environment to Evaluate Closed-Loop Insulin Delivery Systems in Type 1 DiabetesJournal of Diabetes Science and Technology, 2010
- Estimation of the Warfarin Dose with Clinical and Pharmacogenetic DataNew England Journal of Medicine, 2009
- Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of WarfarinClinical Pharmacology & Therapeutics, 2008
- Model predictive control for optimal oral anticoagulant drug administrationAIChE Journal, 2006
- The unequal variance t-test is an underused alternative to Student's t-test and the Mann–Whitney U testBehavioral Ecology, 2006